Susceptibility to the novel coronavirus disease (COVID-19) is associated with ABO and Rh blood groups: a case-control study from Afghanistan.

BACKGROUND

There are preliminary studies about the association between COVID-19 and ABO phenotypes and the results are controversial. There are only two studies which investigated the association of Rh blood groups in addition to ABO with COVID-19; however, in the statistical analysis ABO and Rh blood groups have been considered separately. Therefore, the present case-control study was performed to determine the association of COVID-19 with ABO blood groups considering the Rh blood groups simultaneously. The study was conducted in Kunduz COVID-19 treatment specific center, Spin-Zar Hospital (Kunduz Province, North East Afghanistan). A total of 301 confirmed COVID-19 cases and 1039 healthy blood donors as control group were included in the study.

RESULTS

The Rh phenotype strongly increased the risk of COVID-19 (OR = 2.97, 95% CI 1.86-3.89, < 0.001). Although blood group A increased the risk of developing COVID-19, the association did not reach statistical significance. In analysis of the combination phenotypes, the A blood group remarkably increased the risk of COVID-19 (OR = 7.24, 95% CI 3.62-14.4, < 0.001). Multivariate analysis revealed that the interaction of Rh and ABO is significant ( < 0.013).

CONCLUSION

These findings indicate that susceptibility to COVID-19 is strongly associated with A blood group.